Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13975155 | 0.98 | CYP3A4 (0.46) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL13975612 | 0.98 | CYP3A4 (0.46) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL16449339 | 0.96 | CYP3A4 (0.46) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL13976013 | 0.95 | CYP3A4 (0.47) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL16449306 | 0.94 | CYP3A4 (0.46) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL13975790 | 0.93 | CYP3A4 (0.45) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL16449308 | 0.93 | CYP3A4 (0.47) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL13975127 | 0.93 | CYP3A4 (0.46) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL16449343 | 0.92 | CYP3A4 (0.45) | CYP3A4ADRB3ADRA2BADRA2CCTSB | |
| SCHEMBL13976020 | 0.92 | CYP3A4 (0.45) | CYP3A4ADRB3ADRA2BADRA2CCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8951964-B2 | Phenanthridine macrocyclic hepatitis C serine protease inhibitors | ABBVIE INC. (US) | 2015-02-10 | — | — | US | disclosed |